Author

T. C. Hobman

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:human· 2 Approach:deep learning· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

D. Limonta· 2 shared A. Glasgow· 1 shared A. P. Wiita· 1 shared C. Power· 1 shared I. Lui· 1 shared J. A. Wells· 1 shared J. E. Glasgow· 1 shared J. V. Ravetch· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

D. Limonta

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivNov 5, 2020

Nodosome inhibition as a novel broad-spectrum antiviral strategy against arboviruses and SARS-CoV-2

D. Limonta, L. Dyna-Dagman, W. Branton…·T. C. Hobman

The paper identifies two small molecules that inhibit nodosome formation, showing broad-spectrum antiviral activity against ZIKV, flaviviruses, alphaviruses, and SARS-CoV-2 by enhancing the interferon response.

DOI 10.1128/aac.00491-21

humanexperimental assay

𝕏 PostBluesky

BioengineeringbioRxivJul 31, 2020

Engineered ACE2 receptor traps potently neutralize SARS-CoV-2

A. Glasgow, J. E. Glasgow, D. Limonta…·J. A. Wells

This paper describes engineered ACE2 receptor traps that potently neutralize SARS-CoV-2 by blocking viral entry through enhanced binding affinity.

DOI 10.1073/pnas.2016093117

humanproteomics

𝕏 PostBluesky